Shell Asset Management CO Sangamo Therapeutics, Inc Transaction History

Shell Asset Management CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$3.28 - $6.21 $239 - $453	73 Added 0.17%	42,138 $174,000
Q1 2022 May 04, 2022	SELL	$5.23 - $7.82 $32,582 - $48,718	-6,230 Reduced 12.9%	42,065 $244,000
Q4 2021 Feb 09, 2022	BUY	$7.29 - $10.97 $92,254 - $138,825	12,655 Added 35.51%	48,295 $362,000
Q3 2021 Nov 04, 2021	SELL	$9.01 - $12.01 $13,785 - $18,375	-1,530 Reduced 4.12%	35,640 $321,000
Q2 2021 Aug 12, 2021	BUY	$10.17 - $12.64 $20,441 - $25,406	2,010 Added 5.72%	37,170 $445,000
Q1 2021 May 10, 2021	BUY	$10.88 - $17.05 $382,540 - $599,478	35,160 New	35,160 $441,000

133

86.3M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $136M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.